Kuruma Tessei, Miyazaki Hidetaka, Takahashi Yasuhiro, Arimoto Mariko, Yo Kinga, Ogawa Tetsuya, Fujimoto Yasushi
Department of Otorhinolaryngology, Head and Neck Surgery, Aichi Medical University Hospital, 1-1 Yazakokarimata, Nagakute-shi, Aichi, 480-1195, Japan.
Department of Oculoplastic, Orbital, and Lacrimal Surgery, Aichi Medical University Hospital, Nagakute, Aichi, Japan.
Eur Arch Otorhinolaryngol. 2025 Jan;282(1):225-233. doi: 10.1007/s00405-024-08994-2. Epub 2024 Oct 2.
This study aimed to clarify the differences in the pathophysiology of maxillary sinus fungus balls (FB) among different case groups and to identify which patients with maxillary sinus FB would be suitable for outpatient procedures.
Thirty-four patients diagnosed with maxillary sinus FB between January 2017 and December 2021 were divided into two groups (O and S). We retrospectively compared the clinical and imaging characteristics, and the treatment outcomes between the groups. Group O comprised 12 patients (13 sides) treated in an outpatient clinic and Group S comprised 15 patients (16 sides) treated with endoscopic sinus surgery (ESS).
Compared to Group S, Group O had more patients with an enlarged maxillary sinus membranous portion, and shadows indicative of fungal masses (P < 0.01 and P < 0.05, respectively). In particular, the anteroposterior ratio of the open maxillary sinus membranous area was 0.68 ± 0.16 in Group O and 0.5 ± 0.12 in Group S. After surgery, Group O exhibited greater anteroposterior expansion of the maxillary sinus membranous portion compared to Group S (P < 0.01). Additionally, Group O had more patients with shadows in sinuses other than the maxillary sinus (P < 0.01) and medial displacement of the uncinate process (P < 0.01) than Group S. In addition, Group O required fewer procedures and hospital visits than Group S (P < 0.001 and P < 0.01, respectively).
Determining the indications for outpatient procedures while considering the pathophysiology of maxillary sinus FB can significantly benefit patients and medical professionals in terms of safety and medical costs.
本研究旨在阐明不同病例组上颌窦真菌球(FB)病理生理学的差异,并确定哪些上颌窦FB患者适合门诊手术。
将2017年1月至2021年12月期间诊断为上颌窦FB的34例患者分为两组(O组和S组)。我们回顾性比较了两组的临床和影像学特征以及治疗结果。O组包括12例(13侧)在门诊治疗的患者,S组包括15例(16侧)接受鼻内镜鼻窦手术(ESS)治疗的患者。
与S组相比,O组上颌窦膜性部分扩大以及存在真菌团块阴影的患者更多(分别为P < 0.01和P < 0.05)。特别是,开放的上颌窦膜性区域的前后径比值在O组为0.68±0.16,在S组为0.5±0.12。手术后,与S组相比,O组上颌窦膜性部分的前后径扩张更大(P < 0.01)。此外,O组上颌窦以外鼻窦有阴影的患者(P < 0.01)和钩突内侧移位的患者(P < 0.01)比S组更多。此外,O组比S组所需的手术和就诊次数更少(分别为P < 0.001和P < 0.01)。
在考虑上颌窦FB病理生理学的同时确定门诊手术的适应症,在安全性和医疗成本方面可使患者和医疗专业人员显著受益。